InvestorsHub Logo
Followers 13
Posts 865
Boards Moderated 0
Alias Born 02/17/2017

Re: iKnow777 post# 35281

Wednesday, 02/06/2019 12:37:09 PM

Wednesday, February 06, 2019 12:37:09 PM

Post# of 232961
I'm with you. Although Gilead is often heralded as the kings of the HIV market - and they do own the lion's share currently - it's not like they're the only ones who are selling HIV treatments. Notably, GSK and Merck are also players in that market and could easily scale up no doubt. I'm sure neither of them would mind drinking Gilead's milkshake in that space.

https://www.statista.com/statistics/273434/revenue-of-the-worlds-most-important-aids-drugs/

Let's not pretend that other BP don't have the inroads and that Gilead is our only hope for hypothetical market penetration in 2020.

Oh, and they both (Merck, GSK) happen to be big oncology players. Just saying.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News